Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2011
Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptidesPeter Laverman, Lieke Joosten, Annemarie Eek, et al.International Journal of Cancer|September 18, 2008
Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agentAldo Mancini, Antonella Borrelli, Antonella Schiattarella, et al.British Journal of Haematology|March 29, 2014
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphomaFilippo Russo, Gaetano Corazzelli, Ferdinando Frigeri, et al.Oncotarget|August 31, 2015
Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trialAntonio Avallone, Biagio Pecori, Franco Bianco, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumabSecondo Lastoria, Maria Carmela Piccirillo, Corradina Caracò, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2025
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary AldosteronismDaniel Gillett, Russell Senanayake, James MacFarlane, et al.Nuclear Medicine Communications|February 26, 2026
The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [18F] fluorodeoxyglucose PETMelissa Lenaerts, Lois van der Voort, Marjolein L Smidt, et al.EJNMMI Research|May 7, 2022
Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtractionDaniel Gillett, Russell Senanayake, James MacFarlane, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry ResultsErik S Mittra, Lilja B Solnes, Astrid A M van der Veldt, et al.Journal of Nuclear Medicine Technology|October 21, 2025
Voxel-Level Comparison of [18F]CETO and [11C]MTO for Molecular Imaging of Primary AldosteronismDaniel Gillett, James MacFarlane, Emily Goodchild, et al.Pageof 9